IX1:ETR
IDEXX Laboratories Inc
500,80 €
arrow_upward
+2,29%(+11,20) 1 d.
17. apr., 17:35:46 GMT+2 · EUR
search
Visi simboli
1 d.
5 d.
1 m.
6 m.
Š.g.
1 g.
5 g.
Maks.
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
Ziņas un raksti
No avotiem tīmeklī
Yahoo Finance
·
pirms 5 stundām
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
TipRanks
·
pirms 10 stundām
Why Idexx Laboratories Stock Is Surging Again Today
Simply Wall Street
·
pirms 3 dienām
A Look At IDEXX Laboratories (IDXX) Valuation After Mixed Recent Share Price Performance
Profils
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
MI saturā var būt kļūdas. Uzzināt vairāk